University of Arizona
Tucson, Arizona, 85721, United States
NCT Number: NCT06430879
This minimal risk, randomized, double-blind, placebo controlled Institutional Review Board (IRB)-approved observational study with functional measurements, will evaluate athletic performance after use of a drug- free, non-invasive patch (VICTORY Patch; The Super Patch Company Inc.); using KangaTech, Catapult and Force Plates along with crossover control of trials within the same subject group not receiving an 'active' patch.
Looking for future studies?
Notify Me18 year–30 year
All sexes
Interventional
Not applicable
Tucson, Arizona, 85721, United States
Emerging technologies that use haptic (skin pressure) technology have been studied and have shown positive improvements in stress levels, balance, sleep, and pain. The VICTORY patch (SuperPatch Company, Toronto, Canada) that also incorporates this technology has shown anecdotal promise to improve athlete performance. With the tools currently in use at the University of Arizona, team coaches and physicians can measure the true impact of neuromuscular changes suggested by the VICTORY patch. This study will measure quadriceps and hamstring strength in isolation as well as peak output in jumping and speed testing within in season training programs with and without VICTORY patch use. When combined with new methods of assessing individual muscle strength (KangaTech) and Force plate as well as Catapult measurements of compound movements of the investigational muscles, the investigators can evaluate the true performance and changes in football athletes with the SuperPatch technology.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Drug- free, non-invasive patch (VICTORY Patch) with haptic vibrotactile trigger technology (VTT)
Other names: Haptic Vibrotactile Trigger Technology, VTT
Sham Patch without haptic vibrotactile trigger technology (VTT)
Other names: Sham Comparator
Time frame: 10 days
Evaluation of change in quadriceps and hamstring function via KangaTech measurements (mm/Kg)
Time frame: 10 days
Evaluation of change in max power of the Ground Reaction Force (GRF) in quadriceps and hamstring function measured by the Vald force plate (F = m * a ; 1 m/s2).
Time frame: 10 days
Evaluation of of Catapult Global Positioning System (GPS) and change in quadriceps and hamstring function to capture maximum acceleration and maximum speed (meters per second (m/s)) during their field workout.
Time frame: 10 days
Evaluation of change in subject response to The Borg Rating of Perceived Exertion (RPE) (scale= 1- 10)
Time frame: 10 days
Evaluation of performance (overall scores) based on concentration of patch placement among study subjects on either dominant medial forearm or dominant side, or mid-anterior thigh.
Time frame: 10 days
Evaluation of predictive baseline metrics of playing position and predictive modeling will be used to identify subject phenotype(s) with an optimal, and a least positive, response. The data used as inputs to construct the predictive models will be a collection of the survey results collected from patients at day 0. Optimal and least positive responses will be defined based on changes in performance and other functional measurement scores, and changes in concomitant medications used, in the treatment group between survey dates.
Time frame: 10 days
Evaluation of reported side effects during study period based on self-report by subject or reported by clinician investigator.
SuperPatch Limited LLC
Industry
POWER-UP Trial (Performance Output With Haptics - Evaluating Athlete Response and Unrealized Potential)
Acronym: POWER-UP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05222295
COPD, Chronic Disease
Istanbul, Zeytinburnu, Turkey (Türkiye)
View Trial DetailsNCT05573139
Muscle Strength, Muscle Weakness
São Paulo, Brazil
View Trial DetailsNCT02994641
Behavior, Motor Activity
Boston, Massachusetts, United States
View Trial DetailsNCT06703749
Muscle Damage, Muscle Strength
Scottsdale, Arizona, United States
View Trial Details